투석기 시장 보고서 : 유형, 용도, 최종사용자, 지역별(2026-2034년)

The global dialyzer market size reached USD 4.0 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 5.8 Billion by 2034, exhibiting a growth rate (CAGR) of 4.19% during 2026-2034. North America dominated the market in 2025. The growing preferences for home dialysis, rising prevalence of lifestyle-related diseases, such as diabetes and hypertension, which often lead to kidney problems, increasing demand for dialysis services, and implementation of supportive government policies and reimbursement programs are some of the factors contributing to the dialyzer market share.

A dialyzer, also known as an artificial kidney, is an apparatus manufactured using a thin and fibrous material to form a semipermeable membrane, which allows smaller particles and liquids to pass through. It is a cost-effective solution that removes excess fluids and wastes from the blood when kidneys are unable to function properly and prevents accumulation of salt and poisoning. It offers several advantages, such as less waste disposal, minimizing environmental impact, decreasing the frequency of first use syndrome, and improving biocompatibility. As a result, it finds extensive applications in in-center dialysis and home dialysis across the globe.

DIALYZER MARKET TRENDS:

Growing Prevalence of Chronic Kidney Disease (CKD)

Chronic kidney disease (CKD) often advances to end-stage renal disease, where dialysis becomes essential for patient survival. A growing number of diabetes and hypertension cases, both key risk factors, are contributing significantly to kidney failure rates, increasing the need for dialysis treatment worldwide. This growing patient base is motivating dialyzer manufacturers to enhance product efficiency and performance. At the same time, broader awareness of kidney-related health issues is driving earlier detection and proactive management, further fueling industry expansion. According to the 2023 ISN-Global Kidney Health Atlas (ISN-GKHA) report, around 850 Million people globally were affected by CKD. These trends underscore the importance of accurate dialyzer market forecast data to support planning and investment in the sector.

Growing Elderly Population Increasing Demand for Renal Care

The expanding elderly population is one of the main factors behind the rising need for dialysis treatment. Kidney function typically declines with age, and chronic conditions like diabetes and hypertension, both leading causes of kidney failure, are more common in older adults. As a result, more individuals require regular hemodialysis, which has increased the consumption of dialyzers. Countries with aging demographics, including Japan, South Korea, Italy, and Germany, are already experiencing the effects of this shift. Healthcare systems are adapting by expanding dialysis centers, increasing funding for chronic kidney care, and encouraging innovation in dialysis equipment. Manufacturers are also focusing on producing dialyzers that are gentler and more efficient, particularly suited for frail patients. This demographic shift is not temporary; it's a structural change that will shape healthcare planning, procurement, and delivery models in the years ahead, especially in regions where older populations are growing fastest.

Increasing Demand for Home Dialysis

Home dialysis treatments are becoming more popular as they give patients the freedom to manage their health without significantly disrupting their routines. This shift is pushing manufacturers to design portable, easy-to-use dialyzers that suit patients' needs for mobility and simplicity. Healthcare providers are also supporting this trend, as home dialysis reduces strain on hospital dialysis units and clinics. New advances in remote monitoring technology are making it easier for medical professionals to supervise treatments remotely, ensuring safety and continuity of care. These developments are contributing to the growth of home-based dialysis solutions. In 2023, Dialyze Direct partnered with Northeast Georgia Health Ventures (NGHV) to deliver onsite home hemodialysis for skilled nursing facility (SNF) residents in Georgia. This initiative aimed to improve outcomes by offering more frequent, gentler dialysis treatments in a familiar setting. According to current dialyzer market analysis, these kinds of partnerships and innovations are expected to play a key role in shaping future demand and product design.

Favorable Government Initiatives and Reimbursement Policies

Several regions are changing their healthcare policies to make dialysis more affordable and easier to access. Subsidies and financial aid programs are helping patients handle the ongoing costs of chronic kidney disease earlier in their treatment. Insurance providers are now covering dialysis more broadly, reducing out-of-pocket expenses and encouraging more people to start treatment sooner. Governments are also supporting hospitals by supplying modern dialysis machines, making sure clinics are better equipped. In 2024, Dr. Mansukh Mandaviya launched 27 greenfield bulk drug parks and 13 new medical device manufacturing plants under India's PLI scheme. Among them were dialyzer manufacturing facilities by Nipro India Corporation in Satara, Maharashtra, and Poly Medicure Limited in Faridabad, Haryana. These plants are meant to strengthen India's ability to produce critical medical devices locally and cut down on imports.

Innovation in Dialysis Technology Enhancing Patient Outcomes

Ongoing advancements in dialysis technology are reshaping the way care is delivered and improving the overall treatment experience for patients. Modern dialyzers are now being designed with high-flux membranes that offer better clearance of toxins while preserving essential proteins, which helps reduce complications. Integration of sensors and digital monitoring systems is also gaining traction, enabling more precise control over fluid removal and treatment parameters. Some systems now support remote monitoring, allowing clinicians to adjust settings in real time based on patient-specific data. These changes not only improve safety but also reduce hospitalization rates and treatment fatigue. Compact and portable dialysis machines are making home-based dialysis more feasible, giving patients greater flexibility and quality of life. In parallel, materials science innovations are helping develop biocompatible membranes that minimize inflammation and clotting. As technology continues to evolve, the focus remains on making dialysis less burdensome, more personalized, and better aligned with long-term patient health goals.

KEY MARKET SEGMENTATION:

Breakup by Type:

• High-Flux Dialyzer
• Low-Flux Dialyzer

Breakup by Usage Type:

• Disposable
• Reusable

Breakup by End User:

• Hospitals and Clinics
• Ambulatory Surgical Centers
• Home Care Settings
• Dialysis Centers

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

COMPETITIVE LANDSCAPE:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International Inc., Browndove Healthcare (P) Ltd., Cantel Medical Corporation (Steris plc), Dialife SA, Farmasol, Fresenius Medical Care AG & Co. KGaA, Medica S.p.A., Medtronic plc, Nikkiso Co. Ltd., Nipro Corporation, Shandong Weigao Group Medical Polymer Co. Ltd. and Toray Industries Inc.

KEY QUESTIONS ANSWERED IN THIS REPORT

1. What was the size of the global dialyzer market in 2025?

2. What is the expected growth rate of the global dialyzer market during 2026-2034?

3. What are the key factors driving the global dialyzer market?

4. What has been the impact of COVID-19 on the global dialyzer market?

5. What is the breakup of the global dialyzer market based on the type?

6. What is the breakup of the global dialyzer market based on the usage type?

7. What is the breakup of the global dialyzer market based on the end user?

8. What are the key regions in the global dialyzer market?

9. Who are the key players/companies in the global dialyzer market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Dialyzer Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Type

• 6.1 High-Flux Dialyzer
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Low-Flux Dialyzer
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast

7 Market Breakup by Usage Type

• 7.1 Disposable
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Reusable
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast

8 Market Breakup by End User

• 8.1 Hospitals and Clinics
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Ambulatory Surgical Centers
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Home Care Settings
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Dialysis Centers
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Asahi Kasei Corporation
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
    • 14.3.1.3 Financials
    • 14.3.1.4 SWOT Analysis
  • 14.3.2 B. Braun Melsungen AG
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
    • 14.3.2.3 SWOT Analysis
  • 14.3.3 Baxter International Inc.
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
    • 14.3.3.3 Financials
    • 14.3.3.4 SWOT Analysis
  • 14.3.4 Browndove Healthcare (P) Ltd.
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
  • 14.3.5 Cantel Medical Corporation (Steris plc)
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
    • 14.3.5.3 SWOT Analysis
  • 14.3.6 Dialife SA
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
  • 14.3.7 Farmasol
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
  • 14.3.8 Fresenius Medical Care AG & Co. KGaA
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
    • 14.3.8.3 Financials
    • 14.3.8.4 SWOT Analysis
  • 14.3.9 Medica S.p.A.
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
  • 14.3.10 Medtronic plc
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
    • 14.3.10.3 Financials
    • 14.3.10.4 SWOT Analysis
  • 14.3.11 Nikkiso Co. Ltd.
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio
    • 14.3.11.3 Financials
    • 14.3.11.4 SWOT Analysis
  • 14.3.12 Nipro Corporation
    • 14.3.12.1 Company Overview
    • 14.3.12.2 Product Portfolio
    • 14.3.12.3 Financials
    • 14.3.12.4 SWOT Analysis
  • 14.3.13 Shandong Weigao Group Medical Polymer Co. Ltd.
    • 14.3.13.1 Company Overview
    • 14.3.13.2 Product Portfolio
    • 14.3.13.3 Financials
    • 14.3.13.4 SWOT Analysis
  • 14.3.14 Toray Industries Inc.
    • 14.3.14.1 Company Overview
    • 14.3.14.2 Product Portfolio
    • 14.3.14.3 Financials
    • 14.3.14.4 SWOT Analysis